ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Increased expression of PAWR is associated with breast cancer progression (2005)
Bessa, A. S.; Soares, F. A.; Netto, M. M.; Nagai, M. A.
Source: Applied Cancer Research - Supplement. Conference titles: São Paulo research conference Cancer Today From Molecular Biology to treatment. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS, PROLIFERAÇÃO CELULAR, APOPTOSE, BIOMARCADORES, REAÇÃO EM CADEIA POR POLIMERASE, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BESSA, A. S. et al. Increased expression of PAWR is associated with breast cancer progression. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Bessa, A. S., Soares, F. A., Netto, M. M., & Nagai, M. A. (2005). Increased expression of PAWR is associated with breast cancer progression. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo.
NLM
Bessa AS, Soares FA, Netto MM, Nagai MA. Increased expression of PAWR is associated with breast cancer progression. Applied Cancer Research - Supplement. 2005 ;( 2): 53-54.[citado 2026 jan. 22 ]
Vancouver
Bessa AS, Soares FA, Netto MM, Nagai MA. Increased expression of PAWR is associated with breast cancer progression. Applied Cancer Research - Supplement. 2005 ;( 2): 53-54.[citado 2026 jan. 22 ]
Trabalho de evento-resumo periodico
Two substances isolated from Crotalus durissus terrificus (Cdt) snake venom induce antinociception and inhibit tumor growth in a rat model of cancer pain (2005)
Brigatte, P.; Gutierrez, V.; Curi, Rui; Rangel-Santos, A. C.; Guerra, José Luiz; Cury, Y.; Sampaio, S. C.
Source: Applied Cancer Research - Supplement. Conference titles: Research Conference Cancer Today: From Molecular Biology to Treatment. Unidade: ICB
Assunto: FISIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRIGATTE, P. et al. Two substances isolated from Crotalus durissus terrificus (Cdt) snake venom induce antinociception and inhibit tumor growth in a rat model of cancer pain. Applied Cancer Research - Supplement. Ribeirão Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Brigatte, P., Gutierrez, V., Curi, R., Rangel-Santos, A. C., Guerra, J. L., Cury, Y., & Sampaio, S. C. (2005). Two substances isolated from Crotalus durissus terrificus (Cdt) snake venom induce antinociception and inhibit tumor growth in a rat model of cancer pain. Applied Cancer Research - Supplement. Ribeirão Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Brigatte P, Gutierrez V, Curi R, Rangel-Santos AC, Guerra JL, Cury Y, Sampaio SC. Two substances isolated from Crotalus durissus terrificus (Cdt) snake venom induce antinociception and inhibit tumor growth in a rat model of cancer pain. Applied Cancer Research - Supplement. 2005 ;( 2): 94.[citado 2026 jan. 22 ]
Vancouver
Brigatte P, Gutierrez V, Curi R, Rangel-Santos AC, Guerra JL, Cury Y, Sampaio SC. Two substances isolated from Crotalus durissus terrificus (Cdt) snake venom induce antinociception and inhibit tumor growth in a rat model of cancer pain. Applied Cancer Research - Supplement. 2005 ;( 2): 94.[citado 2026 jan. 22 ]
Trabalho de evento-resumo periodico
Differential gene expression profile of fibroblast originated from breast cancer as compared to those derived from normal adjacent tissue from benign disease (2005)
Rozenchan, P. B; Siqueira, S. A. C; Silva Junior, W. A; Katayama, M. L. H; Lourdes, T. L; Lyra, E. C; Goes, J. C. S. G; Folgueira, M. A. A. K; Brentani, M. M
Source: Applied Cancer Research - Supplement. Conference titles: São Paulo research conference Cancer Today From Molecular Biology to treatment. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS, FIBROSSARCOMA, FIBROBLASTOS, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROZENCHAN, P. B et al. Differential gene expression profile of fibroblast originated from breast cancer as compared to those derived from normal adjacent tissue from benign disease. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Rozenchan, P. B., Siqueira, S. A. C., Silva Junior, W. A., Katayama, M. L. H., Lourdes, T. L., Lyra, E. C., et al. (2005). Differential gene expression profile of fibroblast originated from breast cancer as compared to those derived from normal adjacent tissue from benign disease. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo.
NLM
Rozenchan PB, Siqueira SAC, Silva Junior WA, Katayama MLH, Lourdes TL, Lyra EC, Goes JCSG, Folgueira MAAK, Brentani MM. Differential gene expression profile of fibroblast originated from breast cancer as compared to those derived from normal adjacent tissue from benign disease. Applied Cancer Research - Supplement. 2005 ;( 2): 92.[citado 2026 jan. 22 ]
Vancouver
Rozenchan PB, Siqueira SAC, Silva Junior WA, Katayama MLH, Lourdes TL, Lyra EC, Goes JCSG, Folgueira MAAK, Brentani MM. Differential gene expression profile of fibroblast originated from breast cancer as compared to those derived from normal adjacent tissue from benign disease. Applied Cancer Research - Supplement. 2005 ;( 2): 92.[citado 2026 jan. 22 ]
Trabalho de evento-resumo periodico
Expression of the human polycomb group EZH2 gene, a transcriptional repressor in breast carcinoma (2005)
Katayama, M. L. H; Andrade, L. N. S; Chammas, R
Source: Applied Cancer Research - Supplement. Conference titles: São Paulo research conference Cancer Today From Molecular Biology to treatment. Unidade: FM
Subjects: CÉLULAS MORTAS, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KATAYAMA, M. L. H e ANDRADE, L. N. S e CHAMMAS, R. Expression of the human polycomb group EZH2 gene, a transcriptional repressor in breast carcinoma. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Katayama, M. L. H., Andrade, L. N. S., & Chammas, R. (2005). Expression of the human polycomb group EZH2 gene, a transcriptional repressor in breast carcinoma. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo.
NLM
Katayama MLH, Andrade LNS, Chammas R. Expression of the human polycomb group EZH2 gene, a transcriptional repressor in breast carcinoma. Applied Cancer Research - Supplement. 2005 ;( 2): 56.[citado 2026 jan. 22 ]
Vancouver
Katayama MLH, Andrade LNS, Chammas R. Expression of the human polycomb group EZH2 gene, a transcriptional repressor in breast carcinoma. Applied Cancer Research - Supplement. 2005 ;( 2): 56.[citado 2026 jan. 22 ]
Trabalho de evento-resumo periodico
Breast Cancer Response to Doxorubicin in Cultured Tissue Slices from Cannis Familiaris (2005)
Sobral, R. A.; Honda, S. T.; Katayama, M. L. H.; Battlehmer, C. N.; Brentani, M. M.; Folgueira, M. A. A. K.
Source: Applied Cancer Research - Supplement. Conference titles: São Paulo research conference Cancer Today From Molecular Biology to treatment. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS (TERAPIA;QUIMIOTERAPIA), TÉCNICAS CITÓLOGICAS, APOPTOSE, EXPRESSÃO GÊNICA, QUIMIOTERAPIA ADJUVANTE, REAÇÃO EM CADEIA POR POLIMERASE, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOBRAL, R. A. et al. Breast Cancer Response to Doxorubicin in Cultured Tissue Slices from Cannis Familiaris. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Sobral, R. A., Honda, S. T., Katayama, M. L. H., Battlehmer, C. N., Brentani, M. M., & Folgueira, M. A. A. K. (2005). Breast Cancer Response to Doxorubicin in Cultured Tissue Slices from Cannis Familiaris. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo.
NLM
Sobral RA, Honda ST, Katayama MLH, Battlehmer CN, Brentani MM, Folgueira MAAK. Breast Cancer Response to Doxorubicin in Cultured Tissue Slices from Cannis Familiaris. Applied Cancer Research - Supplement. 2005 ;( 2): 67-68.[citado 2026 jan. 22 ]
Vancouver
Sobral RA, Honda ST, Katayama MLH, Battlehmer CN, Brentani MM, Folgueira MAAK. Breast Cancer Response to Doxorubicin in Cultured Tissue Slices from Cannis Familiaris. Applied Cancer Research - Supplement. 2005 ;( 2): 67-68.[citado 2026 jan. 22 ]
Trabalho de evento-resumo periodico
Strategic combination of pCLPG-mediated transfer of the p53 and p19ARF tumor suppressors for gene therapy of melanoma (2005)
Giannetti, A. B.; Soares, R. B. S.; Costanzi-Strauss, Eugenia ; Strauss, B. E.
Source: Applied Cancer Research - Supplement. Conference titles: Research Conference Cancer Today: From Molecular Biology to Treatment. Unidade: ICB
Assunto: HISTOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIANNETTI, A. B. et al. Strategic combination of pCLPG-mediated transfer of the p53 and p19ARF tumor suppressors for gene therapy of melanoma. Applied Cancer Research - Supplement. Ribeirão Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Giannetti, A. B., Soares, R. B. S., Costanzi-Strauss, E., & Strauss, B. E. (2005). Strategic combination of pCLPG-mediated transfer of the p53 and p19ARF tumor suppressors for gene therapy of melanoma. Applied Cancer Research - Supplement. Ribeirão Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Giannetti AB, Soares RBS, Costanzi-Strauss E, Strauss BE. Strategic combination of pCLPG-mediated transfer of the p53 and p19ARF tumor suppressors for gene therapy of melanoma. Applied Cancer Research - Supplement. 2005 ;( 2): 51 res. P038.[citado 2026 jan. 22 ]
Vancouver
Giannetti AB, Soares RBS, Costanzi-Strauss E, Strauss BE. Strategic combination of pCLPG-mediated transfer of the p53 and p19ARF tumor suppressors for gene therapy of melanoma. Applied Cancer Research - Supplement. 2005 ;( 2): 51 res. P038.[citado 2026 jan. 22 ]
Trabalho de evento-resumo periodico
A multigenic tumor supressor vírus for cancer gene therapy (2005)
Gregorio, J. C.; Fratini, P.; Strauss, B. E.; Costanzi-Strauss, Eugenia
Source: Applied Cancer Research - Supplement. Conference titles: Research Conference Cancer Today: From Molecular Biology to Treatment. Unidade: ICB
Assunto: HISTOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GREGORIO, J. C. et al. A multigenic tumor supressor vírus for cancer gene therapy. Applied Cancer Research - Supplement. Ribeirão Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Gregorio, J. C., Fratini, P., Strauss, B. E., & Costanzi-Strauss, E. (2005). A multigenic tumor supressor vírus for cancer gene therapy. Applied Cancer Research - Supplement. Ribeirão Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Gregorio JC, Fratini P, Strauss BE, Costanzi-Strauss E. A multigenic tumor supressor vírus for cancer gene therapy. Applied Cancer Research - Supplement. 2005 ;( 2): 48 res. P032.[citado 2026 jan. 22 ]
Vancouver
Gregorio JC, Fratini P, Strauss BE, Costanzi-Strauss E. A multigenic tumor supressor vírus for cancer gene therapy. Applied Cancer Research - Supplement. 2005 ;( 2): 48 res. P032.[citado 2026 jan. 22 ]
Trabalho de evento-resumo periodico
The increased expression of CCL19 and CCL21 may be associated with lymph node spread in head and neck squamous cell carcinoma (2005)
Campofiorito, C. M. M; Mangone, F. R. R; Pasini, F. S; Maistro, S; Barbeta, L. P; Brunialti, K. C. S.; Snitcovsky, I. M. L.; Lehn, C. N.; Brentani, Maria Mitzi; Federico, Miriam Hatsue Honda
Source: Applied Cancer Research - Supplement. Conference titles: São Paulo research conference Cancer Today From Molecular Biology to treatment. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, CARCINOMA DE CÉLULAS ESCAMOSAS, RNA MENSAGEIRO, CARCINOMA DE CÉLULAS ESCAMOSAS (FISIOPATOLOGIA), REAÇÃO EM CADEIA POR POLIMERASE, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOFIORITO, C. M. M et al. The increased expression of CCL19 and CCL21 may be associated with lymph node spread in head and neck squamous cell carcinoma. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Campofiorito, C. M. M., Mangone, F. R. R., Pasini, F. S., Maistro, S., Barbeta, L. P., Brunialti, K. C. S., et al. (2005). The increased expression of CCL19 and CCL21 may be associated with lymph node spread in head and neck squamous cell carcinoma. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo.
NLM
Campofiorito CMM, Mangone FRR, Pasini FS, Maistro S, Barbeta LP, Brunialti KCS, Snitcovsky IML, Lehn CN, Brentani MM, Federico MHH. The increased expression of CCL19 and CCL21 may be associated with lymph node spread in head and neck squamous cell carcinoma. Applied Cancer Research - Supplement. 2005 ;( 2): 76.[citado 2026 jan. 22 ]
Vancouver
Campofiorito CMM, Mangone FRR, Pasini FS, Maistro S, Barbeta LP, Brunialti KCS, Snitcovsky IML, Lehn CN, Brentani MM, Federico MHH. The increased expression of CCL19 and CCL21 may be associated with lymph node spread in head and neck squamous cell carcinoma. Applied Cancer Research - Supplement. 2005 ;( 2): 76.[citado 2026 jan. 22 ]
Trabalho de evento-resumo periodico
Expression of survivin gene and its splice variants survivin-deltaEx3 and survivin-2B versus p53 expression in astrocytic tumors (2005)
Hu, L. W.; Malheiros, S. F.; Gabbai, A. A.; Strauss, B. E.; Costanzi-Strauss, Eugenia
Source: Applied Cancer Research - Supplement. Conference titles: Research Conference Cancer Today: From Molecular Biology to Treatment. Unidade: ICB
Assunto: HISTOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HU, L. W. et al. Expression of survivin gene and its splice variants survivin-deltaEx3 and survivin-2B versus p53 expression in astrocytic tumors. Applied Cancer Research - Supplement. Ribeirão Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Hu, L. W., Malheiros, S. F., Gabbai, A. A., Strauss, B. E., & Costanzi-Strauss, E. (2005). Expression of survivin gene and its splice variants survivin-deltaEx3 and survivin-2B versus p53 expression in astrocytic tumors. Applied Cancer Research - Supplement. Ribeirão Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Hu LW, Malheiros SF, Gabbai AA, Strauss BE, Costanzi-Strauss E. Expression of survivin gene and its splice variants survivin-deltaEx3 and survivin-2B versus p53 expression in astrocytic tumors. Applied Cancer Research - Supplement. 2005 ;( 2): 55.[citado 2026 jan. 22 ]
Vancouver
Hu LW, Malheiros SF, Gabbai AA, Strauss BE, Costanzi-Strauss E. Expression of survivin gene and its splice variants survivin-deltaEx3 and survivin-2B versus p53 expression in astrocytic tumors. Applied Cancer Research - Supplement. 2005 ;( 2): 55.[citado 2026 jan. 22 ]
Trabalho de evento-resumo periodico
Synergic effects of R715, an antogonist of the bradykinin receptor subtype 1 (BK B1-R) which impaired angiogenesis, and dacarbazine on murine melanoma growth (2005)
Pinheiro, M. C; Andrade, L. N. S; Nonogaki, S; Nantel, F; Battistini, B; Sirrois, P; Chammas, R
Source: Applied Cancer Research - Supplement. Conference titles: São Paulo research conference Cancer Today From Molecular Biology to treatment. Unidade: FM
Subjects: MELANOMA, BRADICININA, QUIMIOTERÁPICOS, FÁRMACOS, RECEPTORES, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINHEIRO, M. C et al. Synergic effects of R715, an antogonist of the bradykinin receptor subtype 1 (BK B1-R) which impaired angiogenesis, and dacarbazine on murine melanoma growth. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Pinheiro, M. C., Andrade, L. N. S., Nonogaki, S., Nantel, F., Battistini, B., Sirrois, P., & Chammas, R. (2005). Synergic effects of R715, an antogonist of the bradykinin receptor subtype 1 (BK B1-R) which impaired angiogenesis, and dacarbazine on murine melanoma growth. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo.
NLM
Pinheiro MC, Andrade LNS, Nonogaki S, Nantel F, Battistini B, Sirrois P, Chammas R. Synergic effects of R715, an antogonist of the bradykinin receptor subtype 1 (BK B1-R) which impaired angiogenesis, and dacarbazine on murine melanoma growth. Applied Cancer Research - Supplement. 2005 ;( 2): 98-99.[citado 2026 jan. 22 ]
Vancouver
Pinheiro MC, Andrade LNS, Nonogaki S, Nantel F, Battistini B, Sirrois P, Chammas R. Synergic effects of R715, an antogonist of the bradykinin receptor subtype 1 (BK B1-R) which impaired angiogenesis, and dacarbazine on murine melanoma growth. Applied Cancer Research - Supplement. 2005 ;( 2): 98-99.[citado 2026 jan. 22 ]
Trabalho de evento-resumo periodico
Uninvolved lymph nodes commonly modulated by the presence of breast cancer cells (2005)
Santos, R. P. C; Rozenchan, P. B; Katayama, M. L. H; Brentani, H. P; Carraro, D. M; Patrao, D. F. C; Mota, L. D. C; Bastos, E. P; Lyra, E. C; Goes, J. C. S. G; Brentani, M. M; Folgueira, M. A. A. K
Source: Applied Cancer Research - Supplement. Conference titles: São Paulo research conference Cancer Today From Molecular Biology to treatment. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS, LINFONODOS, CÉLULAS EPITELIAIS, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, R. P. C et al. Uninvolved lymph nodes commonly modulated by the presence of breast cancer cells. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Santos, R. P. C., Rozenchan, P. B., Katayama, M. L. H., Brentani, H. P., Carraro, D. M., Patrao, D. F. C., et al. (2005). Uninvolved lymph nodes commonly modulated by the presence of breast cancer cells. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo.
NLM
Santos RPC, Rozenchan PB, Katayama MLH, Brentani HP, Carraro DM, Patrao DFC, Mota LDC, Bastos EP, Lyra EC, Goes JCSG, Brentani MM, Folgueira MAAK. Uninvolved lymph nodes commonly modulated by the presence of breast cancer cells. Applied Cancer Research - Supplement. 2005 ;( 2): 79-80.[citado 2026 jan. 22 ]
Vancouver
Santos RPC, Rozenchan PB, Katayama MLH, Brentani HP, Carraro DM, Patrao DFC, Mota LDC, Bastos EP, Lyra EC, Goes JCSG, Brentani MM, Folgueira MAAK. Uninvolved lymph nodes commonly modulated by the presence of breast cancer cells. Applied Cancer Research - Supplement. 2005 ;( 2): 79-80.[citado 2026 jan. 22 ]
Trabalho de evento-resumo periodico
Extracellular Galectin-3 Destabilizes Adhesion Plaques by Interacting With B1 Integrin (2005)
Melo, F. H. M.; Butera, D.; Santos, M. F.; Chammas, R.
Source: Applied Cancer Research - Supplement. Conference titles: São Paulo research conference Cancer Today From Molecular Biology to treatment. Unidade: FM
Subjects: INTEGRINAS, SARCOMA, METÁSTASE NEOPLÁSICA, TÉCNICAS CITOLÓGICAS, ADEREÊNCIA CELULAR, RATOS, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELO, F. H. M. et al. Extracellular Galectin-3 Destabilizes Adhesion Plaques by Interacting With B1 Integrin. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Melo, F. H. M., Butera, D., Santos, M. F., & Chammas, R. (2005). Extracellular Galectin-3 Destabilizes Adhesion Plaques by Interacting With B1 Integrin. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo.
NLM
Melo FHM, Butera D, Santos MF, Chammas R. Extracellular Galectin-3 Destabilizes Adhesion Plaques by Interacting With B1 Integrin. Applied Cancer Research - Supplement. 2005 ;( 2): 65.[citado 2026 jan. 22 ]
Vancouver
Melo FHM, Butera D, Santos MF, Chammas R. Extracellular Galectin-3 Destabilizes Adhesion Plaques by Interacting With B1 Integrin. Applied Cancer Research - Supplement. 2005 ;( 2): 65.[citado 2026 jan. 22 ]
Trabalho de evento-resumo periodico
Gene expression profile of non-malignant melanocytic lesions (2005)
Muto, Nair Hideki ; Marques, S. M; Patrão, Diogo Ferreira da Costa ; Camargo, L. P; Esteves, G. H; Neves, E. J; Carvalho, A. F; Landman, G; Neves, R. I; Chammas, R; Reis, L. F. L
Source: Applied Cancer Research - Supplement. Conference titles: São Paulo research conference Cancer Today From Molecular Biology to treatment. Unidade: FM
Subjects: NEOPLASIAS CUTÂNEAS, MELANOMA, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUTO, Nair Hideki et al. Gene expression profile of non-malignant melanocytic lesions. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Muto, N. H., Marques, S. M., Patrão, D. F. da C., Camargo, L. P., Esteves, G. H., Neves, E. J., et al. (2005). Gene expression profile of non-malignant melanocytic lesions. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo.
NLM
Muto NH, Marques SM, Patrão DF da C, Camargo LP, Esteves GH, Neves EJ, Carvalho AF, Landman G, Neves RI, Chammas R, Reis LFL. Gene expression profile of non-malignant melanocytic lesions. Applied Cancer Research - Supplement. 2005 ;( 2): 91.[citado 2026 jan. 22 ]
Vancouver
Muto NH, Marques SM, Patrão DF da C, Camargo LP, Esteves GH, Neves EJ, Carvalho AF, Landman G, Neves RI, Chammas R, Reis LFL. Gene expression profile of non-malignant melanocytic lesions. Applied Cancer Research - Supplement. 2005 ;( 2): 91.[citado 2026 jan. 22 ]
Trabalho de evento-resumo periodico
High pathologic response rate of neoadjuvant chemoradiation with gemcitabine in locally advanced vulvar carcinoma (2005)
Diz, M. D. P. E; Queiroz, C. J. S; Carvalho, J. P; Petitto, V; Nadalin, W; Folgueira, M. A. A. K; Almeida, G. F. G; Federico, M. H. H
Source: Applied Cancer Research - Supplement. Conference titles: São Paulo research conference Cancer Today From Molecular Biology to treatment. Unidade: FM
Subjects: NEOPLASIAS DOS GENITAIS FEMININOS, RADIOTERAPIA, RESUMOS (EVENTOS), QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DIZ, M. D. P. E et al. High pathologic response rate of neoadjuvant chemoradiation with gemcitabine in locally advanced vulvar carcinoma. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Diz, M. D. P. E., Queiroz, C. J. S., Carvalho, J. P., Petitto, V., Nadalin, W., Folgueira, M. A. A. K., et al. (2005). High pathologic response rate of neoadjuvant chemoradiation with gemcitabine in locally advanced vulvar carcinoma. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo.
NLM
Diz MDPE, Queiroz CJS, Carvalho JP, Petitto V, Nadalin W, Folgueira MAAK, Almeida GFG, Federico MHH. High pathologic response rate of neoadjuvant chemoradiation with gemcitabine in locally advanced vulvar carcinoma. Applied Cancer Research - Supplement. 2005 ;( 2): 95.[citado 2026 jan. 22 ]
Vancouver
Diz MDPE, Queiroz CJS, Carvalho JP, Petitto V, Nadalin W, Folgueira MAAK, Almeida GFG, Federico MHH. High pathologic response rate of neoadjuvant chemoradiation with gemcitabine in locally advanced vulvar carcinoma. Applied Cancer Research - Supplement. 2005 ;( 2): 95.[citado 2026 jan. 22 ]
Trabalho de evento-resumo periodico
Analysis of differentially expressed genes in tongue squamous cell carcinoma with/without lymph node metastasis (2005)
Maistro, S; Mangone, F. R. R; Pasini, F. S; Campofiorito, C. M. M; Barbeta, L. P; Walder, F; Lehn, C. N.; Carvalho, B; Brentani, Maria Mitzi; Federico, Miriam Hatsue Honda
Source: Applied Cancer Research - Supplement. Conference titles: São Paulo research conference Cancer Today From Molecular Biology to treatment. Unidade: FM
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, LINFONODOS, NEOPLASIAS DA LÍNGUA, CARCINOMA DE CÉLULAS ESCAMOSAS, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAISTRO, S et al. Analysis of differentially expressed genes in tongue squamous cell carcinoma with/without lymph node metastasis. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Maistro, S., Mangone, F. R. R., Pasini, F. S., Campofiorito, C. M. M., Barbeta, L. P., Walder, F., et al. (2005). Analysis of differentially expressed genes in tongue squamous cell carcinoma with/without lymph node metastasis. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo.
NLM
Maistro S, Mangone FRR, Pasini FS, Campofiorito CMM, Barbeta LP, Walder F, Lehn CN, Carvalho B, Brentani MM, Federico MHH. Analysis of differentially expressed genes in tongue squamous cell carcinoma with/without lymph node metastasis. Applied Cancer Research - Supplement. 2005 ;( 2): 76.[citado 2026 jan. 22 ]
Vancouver
Maistro S, Mangone FRR, Pasini FS, Campofiorito CMM, Barbeta LP, Walder F, Lehn CN, Carvalho B, Brentani MM, Federico MHH. Analysis of differentially expressed genes in tongue squamous cell carcinoma with/without lymph node metastasis. Applied Cancer Research - Supplement. 2005 ;( 2): 76.[citado 2026 jan. 22 ]
Trabalho de evento-resumo periodico
Expression of SMAD2 and SMAD6 mRNA seems to be related to prognosis in oral squamous cell carcinoma (2005)
Mangone, F. R. R; Pasini, F. S; Campofiorito, C. M. M; Maistro, S; Walder, F; Lehn, C. N.; Snitcovsky, I. M. L; Brentani, Maria Mitzi; Federico, Miriam Hatsue Honda
Source: Applied Cancer Research - Supplement. Conference titles: São Paulo research conference Cancer Today From Molecular Biology to treatment. Unidade: FM
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, CÉLULAS EPITELIAIS, CARCINOMA DE CÉLULAS ESCAMOSAS, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANGONE, F. R. R et al. Expression of SMAD2 and SMAD6 mRNA seems to be related to prognosis in oral squamous cell carcinoma. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Mangone, F. R. R., Pasini, F. S., Campofiorito, C. M. M., Maistro, S., Walder, F., Lehn, C. N., et al. (2005). Expression of SMAD2 and SMAD6 mRNA seems to be related to prognosis in oral squamous cell carcinoma. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo.
NLM
Mangone FRR, Pasini FS, Campofiorito CMM, Maistro S, Walder F, Lehn CN, Snitcovsky IML, Brentani MM, Federico MHH. Expression of SMAD2 and SMAD6 mRNA seems to be related to prognosis in oral squamous cell carcinoma. Applied Cancer Research - Supplement. 2005 ;( 2): 76.[citado 2026 jan. 22 ]
Vancouver
Mangone FRR, Pasini FS, Campofiorito CMM, Maistro S, Walder F, Lehn CN, Snitcovsky IML, Brentani MM, Federico MHH. Expression of SMAD2 and SMAD6 mRNA seems to be related to prognosis in oral squamous cell carcinoma. Applied Cancer Research - Supplement. 2005 ;( 2): 76.[citado 2026 jan. 22 ]
Trabalho de evento-resumo periodico
Analysis of differentially expressed genes in oral squamous cell carcinoma predictive of metastatic lymph nodes (2005)
Pasini, F. S; Maistro, S; Campofiorito, C. M. M; MANGONE, F. R. R; Walder, F; Carvalho, B; Lehn, C. N; Brentani, Maria Mitzi; Federico, Miriam Hatsue Honda
Source: Applied Cancer Research - Supplement. Conference titles: São Paulo research conference Cancer Today From Molecular Biology to treatment. Unidade: FM
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, LINFONODOS, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASINI, F. S et al. Analysis of differentially expressed genes in oral squamous cell carcinoma predictive of metastatic lymph nodes. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Pasini, F. S., Maistro, S., Campofiorito, C. M. M., MANGONE, F. R. R., Walder, F., Carvalho, B., et al. (2005). Analysis of differentially expressed genes in oral squamous cell carcinoma predictive of metastatic lymph nodes. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo.
NLM
Pasini FS, Maistro S, Campofiorito CMM, MANGONE FRR, Walder F, Carvalho B, Lehn CN, Brentani MM, Federico MHH. Analysis of differentially expressed genes in oral squamous cell carcinoma predictive of metastatic lymph nodes. Applied Cancer Research - Supplement. 2005 ;( 2): 66.[citado 2026 jan. 22 ]
Vancouver
Pasini FS, Maistro S, Campofiorito CMM, MANGONE FRR, Walder F, Carvalho B, Lehn CN, Brentani MM, Federico MHH. Analysis of differentially expressed genes in oral squamous cell carcinoma predictive of metastatic lymph nodes. Applied Cancer Research - Supplement. 2005 ;( 2): 66.[citado 2026 jan. 22 ]
Trabalho de evento-resumo periodico
Assessment of the in vivo expression of the pCLPG retroviral vector in an animal model of bone marrow transplantation (2005)
Fratini, P.; Gregorio, J. C.; Costanzi-Strauss, Eugenia ; Strauss, B. E.
Source: Applied Cancer Research - Supplement. Conference titles: Research Conference Cancer Today: From Molecular Biology to Treatment. Unidade: ICB
Assunto: HISTOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRATINI, P. et al. Assessment of the in vivo expression of the pCLPG retroviral vector in an animal model of bone marrow transplantation. Applied Cancer Research - Supplement. Ribeirão Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Fratini, P., Gregorio, J. C., Costanzi-Strauss, E., & Strauss, B. E. (2005). Assessment of the in vivo expression of the pCLPG retroviral vector in an animal model of bone marrow transplantation. Applied Cancer Research - Supplement. Ribeirão Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Fratini P, Gregorio JC, Costanzi-Strauss E, Strauss BE. Assessment of the in vivo expression of the pCLPG retroviral vector in an animal model of bone marrow transplantation. Applied Cancer Research - Supplement. 2005 ;( 2): 48 res. P031.[citado 2026 jan. 22 ]
Vancouver
Fratini P, Gregorio JC, Costanzi-Strauss E, Strauss BE. Assessment of the in vivo expression of the pCLPG retroviral vector in an animal model of bone marrow transplantation. Applied Cancer Research - Supplement. 2005 ;( 2): 48 res. P031.[citado 2026 jan. 22 ]
Trabalho de evento-resumo periodico
Animal models of prostate and lung cancer expressing green fluorescent protein (2005)
Morais, R. G.; Gregorio, J. C.; Strauss, B. E.; Costanzi-Strauss, Eugenia
Source: Applied Cancer Research - Supplement. Conference titles: Research Conference Cancer Today: From Molecular Biology to Treatment. Unidade: ICB
Assunto: HISTOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAIS, R. G. et al. Animal models of prostate and lung cancer expressing green fluorescent protein. Applied Cancer Research - Supplement. Ribeirão Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Morais, R. G., Gregorio, J. C., Strauss, B. E., & Costanzi-Strauss, E. (2005). Animal models of prostate and lung cancer expressing green fluorescent protein. Applied Cancer Research - Supplement. Ribeirão Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Morais RG, Gregorio JC, Strauss BE, Costanzi-Strauss E. Animal models of prostate and lung cancer expressing green fluorescent protein. Applied Cancer Research - Supplement. 2005 ;( 2): 98.[citado 2026 jan. 22 ]
Vancouver
Morais RG, Gregorio JC, Strauss BE, Costanzi-Strauss E. Animal models of prostate and lung cancer expressing green fluorescent protein. Applied Cancer Research - Supplement. 2005 ;( 2): 98.[citado 2026 jan. 22 ]
Trabalho de evento-resumo periodico
Cellular Prion Protein and its Partners as Apoptosis Regulators (2005)
Lopes, Marilene Hohmuth ; Hajj, G. N. M.; Muras, A. G.; Mancini, G. L.; Castro, R.; Ribeiro, K. B.; Brentani, R. R.; Linden, R.; Martins, V. R.
Source: Applied Cancer Research - Supplement. Conference titles: São Paulo research conference Cancer Today From Molecular Biology to treatment. Unidade: FM
Subjects: TÉCNICAS GENÉTICAS (TENDÊNCIAS), EXPRESSÃO GÊNICA, APOPTOSE, REGULAÇÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Marilene Hohmuth et al. Cellular Prion Protein and its Partners as Apoptosis Regulators. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2005
APA
Lopes, M. H., Hajj, G. N. M., Muras, A. G., Mancini, G. L., Castro, R., Ribeiro, K. B., et al. (2005). Cellular Prion Protein and its Partners as Apoptosis Regulators. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo.
NLM
Lopes MH, Hajj GNM, Muras AG, Mancini GL, Castro R, Ribeiro KB, Brentani RR, Linden R, Martins VR. Cellular Prion Protein and its Partners as Apoptosis Regulators. Applied Cancer Research - Supplement. 2005 ;( 2): 55.[citado 2026 jan. 22 ]
Vancouver
Lopes MH, Hajj GNM, Muras AG, Mancini GL, Castro R, Ribeiro KB, Brentani RR, Linden R, Martins VR. Cellular Prion Protein and its Partners as Apoptosis Regulators. Applied Cancer Research - Supplement. 2005 ;( 2): 55.[citado 2026 jan. 22 ]

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects